Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS). [Phase 1]
A Phase 1 study evaluating safety, biodistribution, radiation dosimetry, and imaging protocol optimization of GEH120714 (18F) injection in h…
-
CLINICAL_TRIALS research · 2016-07-28Clinical Trial Update: Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 2]
Phase 2 proof-of-concept trial investigating RHB-104 as add-on to interferon beta-1a in relapsing-remitting multiple sclerosis has completed…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: DTI in Children With Multiple Sclerosis [NA]
A clinical trial update examining diffusion tensor imaging (DTI) in children with multiple sclerosis, including relapsing-remitting MS and c…
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.
A clinical trial update examining how polymorphisms in interleukin, glypican, and HLA genes influence treatment response in relapsing-remitt…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS [NA]
The trial update describes development of a talk therapy protocol designed to help patients with Relapsing-remitting Multiple Sclerosis make…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]
This document updates on a Phase 1/2 study evaluating allogeneic human umbilical cord-derived mesenchymal stem cells with Liberation Therapy…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating autologous bone marrow-derived mononuclear cells with liberation therapy for CCSVI in relapsing-remitting…
-
CLINICAL_TRIALS research · 2014-07-16Clinical Trial Update: A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects
This is a completed Scandinavian non-interventional study assessing adherence to Rebif administered with the RebiSmart auto-injector in rela…
-
CLINICAL_TRIALS research · 2014-07-14Clinical Trial Update: An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients
This completed observational study evaluated whether high-frequency and higher-dose administration of Rebif (interferon beta-1a) could optim…
-
CLINICAL_TRIALS research · 2014-04-04Clinical Trial Update: Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis [NA]
Clinical trial update on a 12-week respiratory muscle training program for Relapsing-remitting multiple sclerosis; the current status of the…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
A completed clinical trial evaluating sexual dysfunction, disability, and quality of life in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS research · 2013-09-23Clinical Trial Update: Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of NU100 in relapsing-remitting multiple sclerosis, with the current trial st…
-
CLINICAL_TRIALS research · 2012-11-15Clinical Trial Update: BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program
This completed observational trial evaluates adherence to Betaferon (interferon beta-1b) in patients with relapsing-remitting or secondary-p…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors
An observational Portuguese study evaluating adherence in multiple sclerosis patients after conversion to Betaferon (interferon beta-1b) via…
-
CLINICAL_TRIALS research · 2012-10-12Clinical Trial Update: Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial update examining how vitamin A affects RAR gene expression in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS research · 2011-08-16Clinical Trial Update: Impact of Vitamin A on Multiple Sclerosis (MS) [Phase 4]
This clinical trial update from Tehran University of Medical Sciences investigates whether Vitamin A affects relapsing-remitting multiple sc…
-
CLINICAL_TRIALS research · 2010-12-06Clinical Trial Update: A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis [Phase 2]
Phase 2 trial evaluating BMS-188667 in relapsing-remitting multiple sclerosis. The study status is terminated.
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
An update on neurocognitive changes observed in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
-
CLINICAL_TRIALS research · 2010-09-09Clinical Trial Update: A Study for Patients With Relapsing Remitting Multiple Sclerosis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial for Relapsing Remitting Multiple Sclerosis sponsored by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2009-06-05Clinical Trial Update: Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)
A trial is comparing cognitive effects of Campath (alemtuzumab) versus Rebif (interferon beta-1a) in relapsing-remitting multiple sclerosis.…
-
CLINICAL_TRIALS research · 2007-10-16Clinical Trial Update: A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties [Phase 4]
A Phase 4 completed clinical trial update describing an fMRI study to better understand Relapsing-Remitting Multiple Sclerosis and memory di…
-
CLINICAL_TRIALS research · 2006-09-07Clinical Trial Update: Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS [NA]
Clinical trial update evaluating a combination of modafinil (Provigil) and interferon beta-1a (Avonex) to treat cognitive problems in Relaps…